Hillhouse Capital Management - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Hillhouse Capital Management ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2018$46,562,000
+37.1%
813,600
+16.2%
1.24%
+114.9%
Q2 2018$33,964,000
+24.1%
700,0000.0%0.58%
+19.9%
Q1 2018$27,370,000
-7.9%
700,0000.0%0.48%
-4.2%
Q4 2017$29,708,000
+13.7%
700,0000.0%0.50%
+16.7%
Q3 2017$26,124,000
+22.8%
700,0000.0%0.43%
+31.7%
Q2 2017$21,273,000
+14.8%
700,0000.0%0.33%
-8.6%
Q1 2017$18,529,000
+45.2%
700,000
+40.0%
0.36%
+26.0%
Q4 2016$12,760,000
+17.5%
500,000
+66.7%
0.28%
+28.4%
Q3 2016$10,857,000300,0000.22%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,505,012$204,095,00039.96%
Foresite Capital Management III, LLC 108,630$14,731,00012.94%
Avoro Capital Advisors LLC 3,000,000$406,830,0007.03%
Octagon Capital Advisors LP 112,363$15,238,0005.74%
Artal Group S.A. 1,400,000$189,854,0003.36%
Eversept Partners, LP 241,981$32,815,0432.47%
NWI MANAGEMENT LP 200,000$27,122,0002.26%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 60,500$8,199,0002.17%
Affinity Asset Advisors, LLC 45,000$6,102,0002.07%
Parkman Healthcare Partners LLC 62,780$8,514,0001.98%
View complete list of ACCELERON PHARMA INC shareholders